Pee Cee Cosma Sope Ltd Approves Incorporation of Wholly Owned Subsidiary, Abhaya Nourishtech Limited
Pee Cee Cosma Sope Ltd announced the approval, by the Executive Committee of its Board of Directors, for the incorporation of a new Wholly Owned Subsidiary. The Board approved the establishment of the entity, named Abhaya Nourishtech Limited, during a meeting held on April 23, 2026.The newly formed company, Abhaya Nourishtech Limited, will operate in the nutraceutical and food ingredients space. The business scope encompasses milk proteins/plant proteins, food and nutraceutical ingredients, finished products, and related trading activities.
The financial structure and operational details of the subsidiary are as follows:
| Particulars | Details |
|---|---|
| Proposed Company Name | Abhaya Nourishtech Limited |
| Industry Focus | Milk Proteins/Plant Proteins, Food and Nutraceutical Ingredients, and Finished Products |
| Authorized Share Capital | Rs. 5,00,00,000 (Five Crore only), divided into 50,00,000 equity shares of Rs. 10 each. |
| Paid-up Share Capital | Rs. 4,00,00,000 (Four Crore), divided into 40,00,000 equity shares of Re. 10 each. |
| Nature of Consideration | 100% subscription to the initial paid-up share capital in cash. |
| Investment Shareholding | 100% subscription to the initial paid-up share capital in cash. |
| Proposed Incorporation Location | Agra (Uttar Pradesh), India |
The proposed company will be engaged in various activities related to milk proteins/plant proteins, food and nutraceutical ingredients, and finished products. The acquisition is categorized as a related party transaction, as Abhaya Nourishtech Limited is a wholly owned subsidiary of Pee Cee Cosma Sope Ltd. The initial paid-up share capital of Rs. 4,00,00,000 was subscribed entirely in cash.
Stock Price Movement
As of 13:12, shares of Pee Cee Cosma Sope Ltd are dropping, currently at ₹347.00, down 1.22% in today's trading session. The stock moved through a range today, establishing its trading day between a low of ₹340.00 and a high of ₹353.00.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.